Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Advanced peripheral microvascular endothelial dysfunction and polyvascular disease in patients with high cardiovascular risk.
Maeda H, Sugiyama S, Jinnouchi H, Matsuzawa Y, Fujisue K, Hirata Y, Kurokawa H, Ohba K, Matsubara J, Nozaki T, Konishi M, Akiyama E, Sugamura K, Yamamoto E, Sumida H, Ogawa H. Maeda H, et al. Among authors: fujisue k. J Cardiol. 2016 May;67(5):455-62. doi: 10.1016/j.jjcc.2015.07.003. Epub 2015 Sep 4. J Cardiol. 2016. PMID: 26343752 Free article.
Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia: The IAEA INCAPS-COVID Study.
Kudo T, Lahey R, Hirschfeld CB, Williams MC, Lu B, Alasnag M, Bhatia M, Henry Bom HS, Dautov T, Fazel R, Karthikeyan G, Keng FYJ, Rubinshtein R, Better N, Cerci RJ, Dorbala S, Raggi P, Shaw LJ, Villines TC, Vitola JV, Choi AD, Malkovskiy E, Goebel B, Cohen YA, Randazzo M, Pascual TNB, Pynda Y, Dondi M, Paez D, Einstein AJ; INCAPS COVID Investigators Group. Kudo T, et al. JACC Asia. 2021 Sep 21;1(2):187-199. doi: 10.1016/j.jacasi.2021.06.002. eCollection 2021 Sep. JACC Asia. 2021. PMID: 36338167 Free PMC article.
Dipeptidyl peptidase-4 inhibitor, sitagliptin, improves endothelial dysfunction in association with its anti-inflammatory effects in patients with coronary artery disease and uncontrolled diabetes.
Matsubara J, Sugiyama S, Akiyama E, Iwashita S, Kurokawa H, Ohba K, Maeda H, Fujisue K, Yamamoto E, Kaikita K, Hokimoto S, Jinnouchi H, Ogawa H. Matsubara J, et al. Among authors: fujisue k. Circ J. 2013;77(5):1337-44. doi: 10.1253/circj.cj-12-1168. Epub 2013 Feb 2. Circ J. 2013. PMID: 23386232 Free article.
Effects of endothelial dysfunction on residual platelet aggregability after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease.
Fujisue K, Sugiyama S, Ono T, Matsuzawa Y, Akiyama E, Sugamura K, Matsubara J, Kurokawa H, Kaikita K, Iwashita S, Sumida H, Hokimoto S, Oniki K, Nakagawa K, Matsui K, Ogawa H. Fujisue K, et al. Circ Cardiovasc Interv. 2013 Aug;6(4):452-9. doi: 10.1161/CIRCINTERVENTIONS.112.000278. Epub 2013 Aug 6. Circ Cardiovasc Interv. 2013. PMID: 23922147
Successful diet and exercise therapy as evaluated on self-assessment score significantly improves endothelial function in metabolic syndrome patients.
Matsuzawa Y, Sugiyama S, Sugamura K, Sumida H, Kurokawa H, Fujisue K, Konishi M, Akiyama E, Suzuki H, Nakayama N, Yamamuro M, Iwashita S, Jinnouchi H, Kimura K, Umemura S, Ogawa H. Matsuzawa Y, et al. Among authors: fujisue k. Circ J. 2013;77(11):2807-15. doi: 10.1253/circj.cj-13-0549. Epub 2013 Aug 28. Circ J. 2013. PMID: 23986029 Free article.
Response to letter regarding article, "Effects of endothelial dysfunction on residual platelet aggregability after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease".
Fujisue K, Sugiyama S, Ono T, Matsuzawa Y, Akiyama E, Sugamura K, Matsubara J, Kurokawa H, Kaikita K, Iwashita S, Sumida H, Hokimoto S, Oniki K, Nakagawa K, Matsui K, Ogawa H. Fujisue K, et al. Circ Cardiovasc Interv. 2013 Oct 1;6(5):e66. doi: 10.1161/CIRCINTERVENTIONS.113.000788. Circ Cardiovasc Interv. 2013. PMID: 24129939 No abstract available.
Peripheral endothelial function and cardiovascular events in high-risk patients.
Matsuzawa Y, Sugiyama S, Sumida H, Sugamura K, Nozaki T, Ohba K, Matsubara J, Kurokawa H, Fujisue K, Konishi M, Akiyama E, Suzuki H, Nagayoshi Y, Yamamuro M, Sakamoto K, Iwashita S, Jinnouchi H, Taguri M, Morita S, Matsui K, Kimura K, Umemura S, Ogawa H. Matsuzawa Y, et al. Among authors: fujisue k. J Am Heart Assoc. 2013 Nov 25;2(6):e000426. doi: 10.1161/JAHA.113.000426. J Am Heart Assoc. 2013. PMID: 24275629 Free PMC article.
Endothelial function and cardiovascular events in chronic kidney disease.
Hirata Y, Sugiyama S, Yamamoto E, Matsuzawa Y, Akiyama E, Kusaka H, Fujisue K, Kurokawa H, Matsubara J, Sugamura K, Maeda H, Iwashita S, Jinnouchi H, Matsui K, Ogawa H. Hirata Y, et al. Among authors: fujisue k. Int J Cardiol. 2014 May 15;173(3):481-6. doi: 10.1016/j.ijcard.2014.03.085. Epub 2014 Mar 20. Int J Cardiol. 2014. PMID: 24703800
Incremental prognostic significance of the elevated levels of pentraxin 3 in patients with heart failure with normal left ventricular ejection fraction.
Matsubara J, Sugiyama S, Nozaki T, Akiyama E, Matsuzawa Y, Kurokawa H, Maeda H, Fujisue K, Sugamura K, Yamamoto E, Matsui K, Jinnouchi H, Ogawa H. Matsubara J, et al. Among authors: fujisue k. J Am Heart Assoc. 2014 Jul 10;3(4):e000928. doi: 10.1161/JAHA.114.000928. J Am Heart Assoc. 2014. PMID: 25012287 Free PMC article.
Reactive oxidative metabolites are associated with the severity of heart failure and predict future cardiovascular events in heart failure with preserved left ventricular ejection fraction.
Hirata Y, Yamamoto E, Tokitsu T, Kusaka H, Fujisue K, Kurokawa H, Sugamura K, Maeda H, Tsujita K, Yamamuro M, Kaikita K, Hokimoto S, Sugiyama S, Ogawa H. Hirata Y, et al. Among authors: fujisue k. Int J Cardiol. 2015 Jan 20;179:305-8. doi: 10.1016/j.ijcard.2014.11.018. Epub 2014 Nov 5. Int J Cardiol. 2015. PMID: 25464471 No abstract available.
117 results